Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥1,500 26 32 26 32 O
/ 32 33 32 33 I-lower_bound
mcL 33 36 33 36 I-lower_bound

Age 0 3 37 40 B-age
≥18 4 7 41 44 O
years 8 13 45 50 I-lower_bound

Any 0 3 51 54 O
gastrointestinal 4 20 55 71 B-chronic_disease
disorder 21 29 72 80 I-chronic_disease
expected 30 38 81 89 O
to 39 41 90 92 O
limit 42 47 93 98 O
absorption 48 58 99 109 O
of 59 61 110 112 O
IRX4204 62 69 113 120 B-treatment
or 70 72 121 123 O
erlotinib 73 82 124 133 B-treatment

Documented 0 10 134 144 O
disease 11 18 145 152 O
progression 19 30 153 164 O
on 31 33 165 167 O
at 34 36 168 170 O
least 37 42 171 176 O
two 43 46 177 180 B-lower_bound
prior 47 52 181 186 O
lines 53 58 187 192 O
of 59 61 193 195 O
chemotherapy 62 74 196 208 B-treatment
for 75 78 209 212 O
advanced 79 87 213 221 O
NSCLC 88 93 222 227 B-cancer

ECOG 0 4 228 232 B-clinical_variable
performance 5 16 233 244 I-clinical_variable
status 17 23 245 251 I-clinical_variable
≤2 24 26 252 254 O

Hemoglobin 0 10 255 265 B-clinical_variable
≥8.5 11 15 266 270 O
g 16 17 271 272 I-lower_bound
/ 17 18 272 273 I-lower_bound
dL 18 20 273 275 I-lower_bound

History 0 7 276 283 O
of 8 10 284 286 O
allergic 11 19 287 295 O
reactions 20 29 296 305 O
attributed 30 40 306 316 O
to 41 43 317 319 O
IRX4204 44 51 320 327 B-allergy_name
or 52 54 328 330 O
erlotinib 55 64 331 340 B-allergy_name
or 65 67 341 343 O
to 68 70 344 346 O
compounds 71 80 347 356 O
of 81 83 357 359 O
similar 84 91 360 367 O
chemical 92 100 368 376 B-allergy_name
or 101 103 377 379 O
biologic 104 112 380 388 B-allergy_name
composition 113 124 389 400 I-allergy_name

Maximum 0 7 401 408 O
daily 8 13 409 414 O
dose 14 18 415 419 O
of 19 21 420 422 O
steroids 22 30 423 431 B-treatment
should 31 37 432 438 O
be 38 40 439 441 O
prednisone 41 51 442 452 B-treatment
20 52 54 453 455 B-upper_bound
mg 55 57 456 458 I-upper_bound
or 58 60 459 461 O
equivalent 61 71 462 472 O

Men 0 3 473 476 B-gender
treated 4 11 477 484 O
or 12 14 485 487 O
enrolled 15 23 488 496 O
on 24 26 497 499 O
this 27 31 500 504 O
protocol 32 40 505 513 O
must 41 45 514 518 O
also 46 50 519 523 O
agree 51 56 524 529 B-contraception_consent
to 57 59 530 532 I-contraception_consent
use 60 63 533 536 I-contraception_consent
highly 64 70 537 543 I-contraception_consent
effective 71 80 544 553 I-contraception_consent
contraception 81 94 554 567 I-contraception_consent
prior 95 100 568 573 O
to 101 103 574 576 O
the 104 107 577 580 O
study 108 113 581 586 O
, 113 114 586 587 O
for 115 118 588 591 O
the 119 122 592 595 O
duration 123 131 596 604 O
of 132 134 605 607 O
study 135 140 608 613 O
participation 141 154 614 627 O
and 155 158 628 631 O
3 159 160 632 633 B-upper_bound
months 161 167 634 640 I-upper_bound
after 168 173 641 646 O
completion 174 184 647 657 O
of 185 187 658 660 O
IRX4204 188 195 661 668 O
administration 196 210 669 683 O

Patients 0 8 684 692 O
must 9 13 693 697 O
have 14 18 698 702 O
histologically 19 33 703 717 O
or 34 36 718 720 O
cytologically 37 50 721 734 O
confirmed 51 60 735 744 O
stage 61 66 745 750 B-cancer
IV 67 69 751 753 I-cancer
non 70 73 754 757 I-cancer
- 73 74 757 758 I-cancer
small 74 79 758 763 I-cancer
cell 80 84 764 768 I-cancer
lung 85 89 769 773 I-cancer
cancer 90 96 774 780 I-cancer

Patients 0 8 781 789 O
with 9 13 790 794 O
a 14 15 795 796 O
history 16 23 797 804 O
of 24 26 805 807 O
active 27 33 808 814 B-chronic_disease
thyroid 34 41 815 822 I-chronic_disease
disease 42 49 823 830 I-chronic_disease

Patients 0 8 831 839 O
with 9 13 840 844 O
a 14 15 845 846 O
history 16 23 847 854 O
of 24 26 855 857 O
another 27 34 858 865 O
active 35 41 866 872 B-cancer
malignancy 42 52 873 883 I-cancer
within 53 59 884 890 O
the 60 63 891 894 O
past 64 68 895 899 B-upper_bound
two 69 72 900 903 I-upper_bound
years 73 78 904 909 I-upper_bound

Pregnant 0 8 910 918 B-pregnancy

Prior 0 5 919 924 B-treatment
topical 6 13 925 932 I-treatment
retinoid 14 22 933 941 I-treatment
use 23 26 942 945 O

Prior 0 5 946 951 O
treatment 6 15 952 961 O
with 16 20 962 966 O
an 21 23 967 969 O
EGFR 24 28 970 974 B-treatment
tyrosine 29 37 975 983 I-treatment
kinase 38 44 984 990 I-treatment
inhibitor 45 54 991 1000 I-treatment

Progression 0 11 1001 1012 O
within 12 18 1013 1019 O
6 19 20 1020 1021 B-upper_bound
months 21 27 1022 1028 I-upper_bound
of 28 30 1029 1031 O
adjuvant 31 39 1032 1040 B-treatment
chemotherapy 40 52 1041 1053 I-treatment
or 53 55 1054 1056 O
definitive 56 66 1057 1067 B-treatment
chemoradiation 67 81 1068 1082 I-treatment
will 82 86 1083 1087 O
count 87 92 1088 1093 O
as 93 95 1094 1096 O
one 96 99 1097 1100 O
line 100 104 1101 1105 O
of 105 107 1106 1108 O
therapy 108 115 1109 1116 O

Radiation 0 9 1117 1126 B-treatment
therapy 10 17 1127 1134 I-treatment
for 18 21 1135 1138 O
brain 22 27 1139 1144 B-cancer
metastases 28 38 1145 1155 I-cancer
must 39 43 1156 1160 O
be 44 46 1161 1163 O
completed 47 56 1164 1173 O
at 57 59 1174 1176 O
least 60 65 1177 1182 O
14 66 68 1183 1185 B-lower_bound
days 69 73 1186 1190 I-lower_bound
prior 74 79 1191 1196 I-lower_bound
to 80 82 1197 1199 O
treatment 83 92 1200 1209 O
on 93 95 1210 1212 O
protocol 96 104 1213 1221 O

Total 0 5 1222 1227 B-clinical_variable
bilirubin 6 15 1228 1237 I-clinical_variable
≤1.5 16 20 1238 1242 O
x 21 22 1243 1244 I-upper_bound
institutional 23 36 1245 1258 I-upper_bound
upper 37 42 1259 1264 I-upper_bound
limit 43 48 1265 1270 I-upper_bound
of 49 51 1271 1273 I-upper_bound
normal 52 58 1274 1280 I-upper_bound
( 59 60 1281 1282 I-upper_bound
ULN 60 63 1282 1285 I-upper_bound
) 63 64 1285 1286 I-upper_bound

cardiac 0 7 1287 1294 B-chronic_disease
arrhythmia 8 18 1295 1305 I-chronic_disease

ductal 0 6 1306 1312 B-cancer
carcinoma 7 16 1313 1322 I-cancer
in 17 19 1323 1325 I-cancer
situ 20 24 1326 1330 I-cancer
which 25 30 1331 1336 O
has 31 34 1337 1340 O
been 35 39 1341 1345 O
successfully 40 52 1346 1358 O
treated 53 60 1359 1366 O
with 61 65 1367 1371 O
curative 66 74 1372 1380 B-treatment
intent 75 81 1381 1387 I-treatment
therapy 82 89 1388 1395 I-treatment

non 0 3 1396 1399 B-cancer
- 3 4 1399 1400 I-cancer
melanoma 4 12 1400 1408 I-cancer
cutaneous 13 22 1409 1418 I-cancer
malignancy 23 33 1419 1429 I-cancer

nursing 0 7 1430 1437 O
women 8 13 1438 1443 B-gender

ongoing 0 7 1444 1451 O
or 8 10 1452 1454 O
active 11 17 1455 1461 B-chronic_disease
infection 18 27 1462 1471 I-chronic_disease

psychiatric 0 11 1472 1483 B-chronic_disease
illness 12 19 1484 1491 I-chronic_disease
/ 19 20 1491 1492 O
social 20 26 1492 1498 O
situations 27 37 1499 1509 O
that 38 42 1510 1514 O
would 43 48 1515 1520 O
limit 49 54 1521 1526 O
compliance 55 65 1527 1537 O
with 66 70 1538 1542 O
study 71 76 1543 1548 O
requirements 77 89 1549 1561 O

recurrent 0 9 1562 1571 O
non 10 13 1572 1575 B-cancer
- 13 14 1575 1576 I-cancer
small 14 19 1576 1581 I-cancer
cell 20 24 1582 1586 I-cancer
lung 25 29 1587 1591 I-cancer
cancer 30 36 1592 1598 I-cancer
which 37 42 1599 1604 O
is 43 45 1605 1607 O
not 46 49 1608 1611 O
amenable 50 58 1612 1620 O
to 59 61 1621 1623 O
curative 62 70 1624 1632 B-treatment
intent 71 77 1633 1639 I-treatment
therapy 78 85 1640 1647 I-treatment

symptomatic 0 11 1648 1659 O
congestive 12 22 1660 1670 B-chronic_disease
heart 23 28 1671 1676 I-chronic_disease
failure 29 36 1677 1684 I-chronic_disease

